489460 — Biobijou Co Income Statement
0.000.00%
Last trade - 00:00- KR₩206bn
- KR₩183bn
- KR₩30bn
Annual income statement for Biobijou Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 17,130 | 29,633 |
| Cost of Revenue | ||
| Gross Profit | 8,274 | 14,852 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Total Operating Expenses | 11,966 | 20,406 |
| Operating Profit | 5,165 | 9,227 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 4,227 | 8,979 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 3,310 | 7,188 |
| Net Income Before Extraordinary Items | ||
| Net Income | 3,310 | 7,188 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 3,310 | 7,188 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 220 | 478 |